Tower Research Capital (TRC)’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-65,203
Closed -$45.6K 6321
2023
Q4
$45.6K Buy
65,203
+41,160
+171% +$28.8K ﹤0.01% 3194
2023
Q3
$16.6K Buy
24,043
+17,071
+245% +$11.8K ﹤0.01% 3550
2023
Q2
$16.8K Buy
6,972
+3,132
+82% +$7.55K ﹤0.01% 3520
2023
Q1
$31K Buy
3,840
+148
+4% +$1.2K ﹤0.01% 2978
2022
Q4
$44K Buy
3,692
+1,263
+52% +$15.1K ﹤0.01% 2454
2022
Q3
$34K Sell
2,429
-27
-1% -$378 ﹤0.01% 3505
2022
Q2
$86K Buy
2,456
+70
+3% +$2.45K ﹤0.01% 2411
2022
Q1
$95K Buy
2,386
+1,613
+209% +$64.2K ﹤0.01% 2243
2021
Q4
$32K Buy
773
+46
+6% +$1.9K ﹤0.01% 3179
2021
Q3
$49K Buy
727
+344
+90% +$23.2K ﹤0.01% 2986
2021
Q2
$29K Buy
383
+254
+197% +$19.2K ﹤0.01% 3547
2021
Q1
$9K Sell
129
-39
-23% -$2.72K ﹤0.01% 4443
2020
Q4
$6K Buy
+168
New +$6K ﹤0.01% 4577
2020
Q3
Sell
-511
Closed -$19K 5185
2020
Q2
$19K Buy
+511
New +$19K ﹤0.01% 3716
2019
Q3
Sell
-13
Closed -$1K 4632
2019
Q2
$1K Buy
+13
New +$1K ﹤0.01% 3518
2017
Q2
Hold
0
3728
2017
Q1
Hold
0
4110
2016
Q4
Sell
-14
Closed -$3K 4541
2016
Q3
$3K Buy
+14
New +$3K ﹤0.01% 2926
2016
Q2
Sell
-4
Closed -$2K 5125
2016
Q1
$2K Buy
+4
New +$2K ﹤0.01% 3476
2015
Q4
Sell
-28
Closed -$7K 5213
2015
Q3
$7K Buy
28
+23
+460% +$5.75K ﹤0.01% 2586
2015
Q2
$2K Buy
+5
New +$2K ﹤0.01% 3814
2014
Q3
Sell
-1
Closed 5015
2014
Q2
$0 Buy
+1
New ﹤0.01% 4803
2014
Q1
Sell
-3
Closed -$1K 5092
2013
Q4
$1K Buy
+3
New +$1K ﹤0.01% 4276